Novo Nordisk Completes Strategic Acquisition to Enhance …

Dec 18, 2024 · The acquisition is expected to have financial implications in 2024 and 2025, reflecting Novo Nordisk’s continued growth and strategic positioning within the healthcare …

CouponFollow Extension

$16
OFF

Novo Completes $16.5bn Takeover Of Catalent | Pharmaphorum

2 weeks from now

2 days ago · Alongside the acquisition, Novo Nordisk has also embarked on a major capital investment programme to build manufacturing capacity in Europe and the US and is on course …

pharmaphorum.com

$16
OFF

Novo Holdings Completes Catalent Acquisition For $16.5bn

2 weeks from now

Dec 19, 2024 · In a strategic follow-up to the acquisition, Novo Nordisk also purchased three of Catalent’s fill-finish facilities from Novo Holdings. They are located in Bloomington in the US …

pharmaceutical-technology.com

$11
OFF

Novo Nordisk $11b Acquisition To Support Manufacturing Capacity

2 weeks from now

Feb 5, 2024 · The company also assured that until the acquisition is completed, Catalent will remain independent and separate from Novo Holdings and Novo Nordisk. Continued …

europeanpharmaceuticalreview.com

$11
OFF

From Big Gains To Strategic Moves: What’s Shaping Novo …

2 weeks from now

Dec 23, 2024 · As Novo Nordisk completes regulatory conditions for the $11.7B acquisition of Catalent, the strategic expansion plan reflects a slight negative financial outlook in the short …

timothysykes.com

13%
OFF

Novo Nordisk’s Strategic Acquisition Of Catalent: Short-term …

2 weeks from now

Jan 17, 2025 · Despite the acquisition’s debt-financing leading to increased interest payments, Novo Nordisk’s operating margin is expected to improve, with a projected 13% compound …

businessinsider.com

7%
OFF

Novo Nordisk A Focused Healthcare Company

2 weeks from now

d ty ) acquisition of three sites by Novo Nordisk completed Diabetes value market share at 33.7%2 Obesity care sales of DKK 65.1 billion (+57% at CER) l tion Rare disease sales of …

novonordisk.com

$995
OFF

List Of 12 Acquisitions By Novo Nordisk (Jan 2025) - Tracxn

2 weeks from now

Jan 10, 2025 · Novo Nordisk has completed 12 acquisitions with an average acquisition amount of $995M.Its most active year was 2023, with 3 acquisitions, and it has averaged nearly 1 …

tracxn.com

FAQs about Novo Nordisk Completes Strategic Acquisition to Enhance … Coupon?

What is Novo Nordisk acquiring?

Novo Nordisk is set to acquire three fill-finish manufacturing sites from Novo Holdings A/S (Novo Holdings) for $11 billion. This agreement is part of a transaction in which Novo Holdings agreed to acquire the contract development and manufacturing organisation (CDMO) Catalent. ...

When will Novo Nordisk acquire three manufacturing sites?

The agreement to acquire the three manufacturing sites was announced on 5 February 2024. For further information, please see the company announcement here. Novo Nordisk now expects the acquisition to be completed in the coming days. ...

Does Novo Nordisk own Catalent?

Novo Nordisk ( (NVO) ) has provided an announcement. Novo Nordisk has successfully completed the acquisition of three manufacturing sites from Novo Holdings, following the latter’s acquisition of Catalent, Inc., a global contract development and manufacturing organization. ...

How will Novo Nordisk's acquisition impact manufacturing capacity?

Acquisition of the three sites will enable the manufacturing capacity to be expanded at scale and speed. Novo Nordisk specified that the transaction is expected to support an incremental increase in the company’s filling capacity from 2026 and onwards. ...

Are Novo Nordisk's three manufacturing sites fair?

An independent financial advisor to Novo Nordisk, Evercore, has provided a fairness opinion to the Board of Directors, concluding that the consideration for the three manufacturing sites is fair from a financial point of view. ...

How will Novo Nordisk's acquisition affect sterile filling capacity?

The acquisition is expected to gradually increase Novo Nordisk's filling capacity from 2026 and onwards. The three manufacturing sites are specialised in the sterile filling of drugs and located in Anagni (Italy), Brussels (Belgium) and Bloomington (Indiana, US). ...